Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Editorial for "Automated Ultrashort Echo Time (UTE) MRI Low Signal Volume Analysis in Stable Pediatric Cystic Fibrosis and After Elexacaftor/Tezacaftor/Ivacaftor Therapy".
Journal: Journal of magnetic resonance imaging : JMRI
Published: March 31, 2026
Oral losartan yields subtherapeutic airway exposure compared to nebulized delivery and fails to improve mucociliary clearance in cystic fibrosis.
Journal: Frontiers in pharmacology
Published: February 09, 2026
Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 21, 2026
Neutrophil store-operated Ca2+ entry: A correctable biomarker of cystic fibrosis lung disease progression.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: July 03, 2025
The CFTR Amplifier Nesolicaftor Rescues TGF-β1 Inhibition of Modulator-Corrected F508del CFTR Function.
Journal: International journal of molecular sciences
Published: August 30, 2022
Is CF airway inflammation still relevant in the era of highly effective modulators?
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: August 26, 2022
CGM patterns in adults with cystic fibrosis-related diabetes before and after elexacaftor-tezacaftor-ivacaftor therapy.
Journal: Journal of clinical & translational endocrinology
Published: May 11, 2022
Losartan ameliorates TGF-β1-induced CFTR dysfunction and improves correction by cystic fibrosis modulator therapies.
Journal: The Journal of clinical investigation
Published: September 22, 2021
Cystic Fibrosis-related Diabetes Is Associated with Worse Lung Function Trajectory despite Ivacaftor Use.
Journal: American journal of respiratory and critical care medicine
Published: September 01, 2021
An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19.
Journal: Frontiers in medicine
Published: November 18, 2020
An Uncommon Cause of Bronchial Obstruction.
Journal: Annals of the American Thoracic Society
Published: October 30, 2020
Last Updated: 09/26/2026